IRadimed Corporation (IRMD) Stock Analysis & Winston Score

IRadimed Corporation makes medical devices that work safely inside MRI machines. MRI scanners use powerful magnets, which means most standard medical equipment cannot be used nearby. IRadimed solves this problem by building MRI-compatible IV infusion pumps and patient monitoring systems — tools that hospitals need to treat patients during MRI scans. Their main customers are hospitals and imaging centers across the United States. The company sells its hardware devices directly to healthcare facilities and also earns recurring revenue from disposable supplies and service contracts. IRadimed operates primarily in the U.S. but has been expanding internationally. Its gross margin of roughly 76% reflects a strong competitive position — the company holds a niche with few direct rivals making FDA-cleared MRI-compatible infusion pumps. The key growth driver is continued adoption of MRI procedures globally, which increases demand for compatible equipment, though the company's small size makes it vulnerable to any regulatory setbacks or reimbursement changes that could slow hospital purchasing.